{"id":36934,"date":"2026-07-09T15:43:43","date_gmt":"2026-07-09T15:43:43","guid":{"rendered":"https:\/\/indiabulletinusa.com\/wordpress\/2026\/07\/09\/dr-mehmet-oz-glp-1-medications-could-slash-obesity-related-healthcare-expenses\/"},"modified":"2026-07-09T15:43:43","modified_gmt":"2026-07-09T15:43:43","slug":"dr-mehmet-oz-glp-1-medications-could-slash-obesity-related-healthcare-expenses","status":"publish","type":"post","link":"https:\/\/indiabulletinusa.com\/wordpress\/2026\/07\/09\/dr-mehmet-oz-glp-1-medications-could-slash-obesity-related-healthcare-expenses\/","title":{"rendered":"Dr. Mehmet Oz: GLP-1 Medications Could Slash Obesity-Related Healthcare Expenses"},"content":{"rendered":"<p><br \/>\n<\/p>\n<h3>Growing Support for GLP-1 Weight Loss Medications in Healthcare<\/h3>\n<p><strong>Washington, DC<\/strong> \u2013 GLP-1 weight-loss drugs are gaining popularity in the United States, and government officials are advocating their use.<\/p>\n<p>During an interview at the Great American State Fair in Washington on July 6, Dr. Mehmet Oz, the CMS Administrator, expressed his favorable view of GLP-1 medications like Ozempic. He emphasized that these drugs can be helpful for people trying to lose weight. However, he noted that they should not replace healthy habits like diet and exercise but rather assist in making these healthier choices easier.<\/p>\n<p>Dr. Oz highlighted that these medications are particularly beneficial for individuals facing challenges such as joint pain or other health issues that limit their mobility.<\/p>\n<p>For eligible individuals, certain GLP-1 drugs are covered by Medicare, especially for those with conditions like high blood pressure or diabetes. Dr. Oz believes that using these medications can lead to overall savings for taxpayers by reducing the need for extensive health services.<\/p>\n<p>He explained, \u201cAbout 70% of healthcare spending relates to chronic conditions, with obesity being a significant contributor. Supporting these drugs is a smart choice.\u201d<\/p>\n<p>Dr. Oz recently introduced a Medicare GLP-1 Bridge program to help more seniors access these medications for a monthly fee of $50, provided they meet specific health criteria and obtain a doctor\u2019s approval.<\/p>\n<p>He acknowledged that many overweight individuals do not have conditions like high blood pressure or diabetes, which currently limits their access to these helpful medications. Dr. Oz aims to change that to enhance overall community health.<\/p>\n<p>While praising the advancements in pharmaceutical treatments, Dr. Oz reminded everyone that relying solely on medications is not enough. He stated, \u201cThe key to a healthy life still lies in proper nutrition, regular exercise, good sleep, managing stress, and having a sense of purpose.\u201d<\/p>\n<p>He wants to inspire individuals to take control of their health, using every available resource, including medications when suitable. Dr. Oz&#8217;s encouraging words remind us that health is a combination of many factors, and each person&#8217;s journey is unique. <\/p>\n<p>In conclusion, while GLP-1 medications may assist in weight management, Dr. Oz emphasizes the importance of maintaining a balanced lifestyle as a holistic approach to health.<\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>Growing Support for GLP-1 Weight Loss Medications in Healthcare Washington, DC \u2013 GLP-1 weight-loss drugs are gaining popularity in the United States, and government officials are advocating their use. During an interview at the Great American State Fair in Washington on July 6, Dr. Mehmet Oz, the CMS Administrator, expressed his favorable view of GLP-1<\/p>\n","protected":false},"author":1,"featured_media":36935,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"footnotes":""},"categories":[32],"tags":[1990,19,21017,18721,48583,3530,18720],"class_list":["post-36934","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-lifestyle","tag-maha","tag-medications","tag-mehmet-mz","tag-obesity","tag-weight-loss"],"_links":{"self":[{"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/posts\/36934","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/comments?post=36934"}],"version-history":[{"count":0,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/posts\/36934\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/media\/36935"}],"wp:attachment":[{"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/media?parent=36934"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/categories?post=36934"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/tags?post=36934"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}